Hydrocephalus-obesity-hypogonadism syndrome

Hydrocephalus-obesity-hypogonadism syndrome, also known as hydrocephalus with obesity and hypogonadism or sometimes referred to in relation to similar phenotypes as a hypothalamic syndrome variant, is an extremely rare genetic condition characterized by the triad of hydrocephalus (abnormal accumulation of cerebrospinal fluid in the brain), obesity, and hypogonadism (underdevelopment or dysfunction of the gonads leading to reduced sex hormone production). The condition primarily affects the central nervous system, endocrine system, and reproductive system. Hydrocephalus may present early in life and can lead to increased intracranial pressure, developmental delays, and intellectual disability if untreated. The obesity is thought to be of hypothalamic origin, suggesting dysfunction in the hypothalamic region of the brain that regulates appetite and energy balance. Hypogonadism manifests as delayed or absent puberty and may include micropenis or cryptorchidism in males. The syndrome has been described in only a very small number of families in the medical literature, making it one of the rarest conditions catalogued in rare disease databases. Some reported cases have suggested an autosomal recessive inheritance pattern, with affected siblings born to unaffected parents, though the genetic basis has not been definitively established. Treatment is symptomatic and supportive. Hydrocephalus may require neurosurgical intervention such as ventriculoperitoneal shunt placement to relieve cerebrospinal fluid pressure. Hormonal replacement therapy may be used to address hypogonadism, and obesity management strategies including dietary and behavioral interventions are typically recommended. Early diagnosis and multidisciplinary care involving neurology, endocrinology, and developmental specialists are important for optimizing outcomes.

Common questions about Hydrocephalus-obesity-hypogonadism syndrome